Profil
Pieter Jaap Gaillard was the founder of to-BBB technologies BV, founded in 2003, where he held the title of Chief Scientific Officer.
He is also the founder of Mireca Medicines GmbH, founded in 2017, where he currently holds the title of Chairman-Supervisory Board.
Dr. Gaillard has a doctorate degree from the University of Leiden and a graduate degree from the University of Utrecht.
Postes actifs de Pieter Jaap Gaillard
| Sociétés | Poste | Début |
|---|---|---|
Mireca Medicines GmbH
Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Develops treatment for hereditary eye disease | Fondateur | 01/01/2017 |
Anciens postes connus de Pieter Jaap Gaillard
| Sociétés | Poste | Fin |
|---|---|---|
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Fondateur | - |
Formation de Pieter Jaap Gaillard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Health Technology |
Mireca Medicines GmbH
Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Develops treatment for hereditary eye disease | Health Technology |
















